Head and Neck Neoplasms
2011 ◽
Vol 32
(suppl 1)
◽
pp. S1-S1
◽
Human medicines European public assessment report (EPAR): Taxespira (previously Docetaxel Hospira UK Limited ), docetaxel, Stomach Neoplasms,Prostatic Neoplasms,Breast Neoplasms,Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 28/08/2015, Revision: 8, Status: Withdrawn
Human medicines European public assessment report (EPAR): Taxotere, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 27/11/1995, Revision: 44, Status: Authorised
Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Breast Neoplasms, Date of authorisation: 22/05/2012, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Breast Neoplasms, Date of authorisation: 21/05/2012, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Docetaxel Zentiva (previously Docetaxel Winthrop), docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 20/04/2007, Revision: 30, Status: Authorised
1993 ◽
Vol 5
(3)
◽
pp. 502-507
◽
K. Kian Ang
◽
William A. Brock
2018 ◽
Vol 13
(3)
◽
pp. 397-414
Peter P. Luk
◽
Christina I. Selinger
◽
Wendy A. Cooper
◽
Annabelle Mahar
◽
Carsten E. Palme
◽
...
1993 ◽
Vol 27
◽
pp. 241-242
W. Wong
◽
D. Haraf
◽
E. Vokes
◽
R. Mick
◽
R. Weichselbaum
1984 ◽
Vol 311
(3)
◽
pp. 201-201
1997 ◽
Vol 147
(3)
◽
pp. 398
Jigna Desai
◽
Bhadrasain Vikram
◽
C. C. Wang